Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/16/2025

Diagnosis of Leukemia with Bone Marrow Biopsy

Diagnostic Approach for Leukemia

  • The initial assessment of leukemia includes peripheral blood evaluation, comprising complete blood count, differential count, and blood smear review, as recommended by the American Society of Clinical Oncology 1, 3
  • If peripheral blood shows sufficient blasts, manual differential count, flow cytometry, fluorescent in situ hybridization, and next-generation sequencing can be performed on the peripheral blood specimen, according to the American Society of Clinical Oncology 2
  • Additional laboratory tests should include comprehensive metabolic panel, lactate dehydrogenase, phosphate, uric acid levels, and coagulation panel, as suggested by the American Society of Clinical Oncology 1, 3

Bone Marrow Examination

  • Bone marrow aspiration and biopsy are typically required for definitive diagnosis of leukemia, as stated by the American Society of Hematology 1, 4
  • For acute leukemia diagnosis, a marrow or blood blast count of 20% or more is required, with some exceptions, according to the World Health Organization 4
  • Morphologic examination includes BM aspirate, touch imprint, cell clots, and core biopsy, as recommended by the American Society of Clinical Oncology 1, 2

Essential Components of Leukemia Diagnosis

Immunophenotyping

  • Multicolor comprehensive flow cytometry panel is essential for diagnosing and classifying leukemia subtypes, as suggested by the American Society of Clinical Oncology 1, 2
  • Flow cytometry should be performed on BM aspirate or PB if no BM aspirate is available, according to the American Society of Clinical Oncology 2

Cytogenetics and Molecular Studies

  • Conventional karyotyping must be performed on BM samples, as recommended by the American Society of Clinical Oncology 2, 4
  • FISH studies are performed according to the suspected leukemia subtype, as suggested by the American Society of Clinical Oncology 2
  • Molecular studies are selective based on the subtype of leukemia, according to the American Society of Clinical Oncology 2, 5

Special Considerations

Acute Leukemia

  • For acute myeloid leukemia, cytochemical studies like myeloperoxidase and nonspecific esterase may be performed on BM or PB, as recommended by the American Society of Hematology 4
  • In acute lymphoblastic leukemia, specific genetic abnormalities require targeted testing, as suggested by the American Society of Clinical Oncology 2, 6